vs

Side-by-side financial comparison of SYPRIS SOLUTIONS INC (SYPR) and EXAGEN INC. (XGN). Click either name above to swap in a different company.

SYPRIS SOLUTIONS INC is the larger business by last-quarter revenue ($30.3M vs $16.6M, roughly 1.8× EXAGEN INC.). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -28.1%, a 15.2% gap on every dollar of revenue. On growth, EXAGEN INC. posted the faster year-over-year revenue change (21.8% vs -9.5%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-3.1M). Over the past eight quarters, EXAGEN INC.'s revenue compounded faster (7.4% CAGR vs -7.7%).

Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.

Exagen Inc. is a clinical diagnostics company specializing in developing, manufacturing, and commercializing proprietary testing solutions for autoimmune, rheumatic, and related chronic diseases. It mainly operates in the U.S. market, serving healthcare providers and patients to support accurate disease diagnosis and treatment monitoring.

SYPR vs XGN — Head-to-Head

Bigger by revenue
SYPR
SYPR
1.8× larger
SYPR
$30.3M
$16.6M
XGN
Growing faster (revenue YoY)
XGN
XGN
+31.3% gap
XGN
21.8%
-9.5%
SYPR
Higher net margin
SYPR
SYPR
15.2% more per $
SYPR
-12.9%
-28.1%
XGN
More free cash flow
SYPR
SYPR
$1.6M more FCF
SYPR
$-1.5M
$-3.1M
XGN
Faster 2-yr revenue CAGR
XGN
XGN
Annualised
XGN
7.4%
-7.7%
SYPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SYPR
SYPR
XGN
XGN
Revenue
$30.3M
$16.6M
Net Profit
$-3.9M
$-4.7M
Gross Margin
4.6%
55.4%
Operating Margin
-10.9%
-29.9%
Net Margin
-12.9%
-28.1%
Revenue YoY
-9.5%
21.8%
Net Profit YoY
-2992.6%
-24.2%
EPS (diluted)
$-0.17
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SYPR
SYPR
XGN
XGN
Q4 25
$30.3M
$16.6M
Q3 25
$28.7M
$17.2M
Q2 25
$31.4M
$17.2M
Q1 25
$29.5M
$15.5M
Q4 24
$33.4M
$13.7M
Q3 24
$35.7M
$12.5M
Q2 24
$35.5M
$15.1M
Q1 24
$35.6M
$14.4M
Net Profit
SYPR
SYPR
XGN
XGN
Q4 25
$-3.9M
$-4.7M
Q3 25
$517.0K
$-7.1M
Q2 25
$-2.1M
$-4.4M
Q1 25
$-899.0K
$-3.8M
Q4 24
$135.0K
$-3.8M
Q3 24
$390.0K
$-5.0M
Q2 24
$16.0K
$-3.0M
Q1 24
$-2.2M
$-3.4M
Gross Margin
SYPR
SYPR
XGN
XGN
Q4 25
4.6%
55.4%
Q3 25
7.2%
58.4%
Q2 25
8.2%
60.4%
Q1 25
11.4%
58.9%
Q4 24
16.1%
62.1%
Q3 24
16.8%
55.8%
Q2 24
15.9%
60.1%
Q1 24
8.1%
59.6%
Operating Margin
SYPR
SYPR
XGN
XGN
Q4 25
-10.9%
-29.9%
Q3 25
-6.1%
-18.0%
Q2 25
-4.6%
-15.3%
Q1 25
-0.4%
-21.7%
Q4 24
3.9%
-24.8%
Q3 24
4.8%
-37.3%
Q2 24
3.6%
-17.2%
Q1 24
-3.9%
-20.8%
Net Margin
SYPR
SYPR
XGN
XGN
Q4 25
-12.9%
-28.1%
Q3 25
1.8%
-41.1%
Q2 25
-6.5%
-25.8%
Q1 25
-3.0%
-24.2%
Q4 24
0.4%
-27.5%
Q3 24
1.1%
-40.2%
Q2 24
0.0%
-19.7%
Q1 24
-6.2%
-23.3%
EPS (diluted)
SYPR
SYPR
XGN
XGN
Q4 25
$-0.17
$-0.21
Q3 25
$0.02
$-0.31
Q2 25
$-0.09
$-0.21
Q1 25
$-0.04
$-0.20
Q4 24
$0.00
$-0.20
Q3 24
$0.02
$-0.28
Q2 24
$0.00
$-0.16
Q1 24
$-0.10
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SYPR
SYPR
XGN
XGN
Cash + ST InvestmentsLiquidity on hand
$32.2M
Total DebtLower is stronger
$22.9M
Stockholders' EquityBook value
$17.8M
$17.4M
Total Assets
$107.8M
$58.0M
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SYPR
SYPR
XGN
XGN
Q4 25
$32.2M
Q3 25
$35.7M
Q2 25
$30.0M
Q1 25
$11.2M
Q4 24
$22.0M
Q3 24
$22.0M
Q2 24
$24.5M
Q1 24
$27.3M
Total Debt
SYPR
SYPR
XGN
XGN
Q4 25
$22.9M
Q3 25
$22.9M
Q2 25
$23.0M
Q1 25
$20.9M
Q4 24
$20.2M
Q3 24
$20.3M
Q2 24
$20.3M
Q1 24
$19.5M
Stockholders' Equity
SYPR
SYPR
XGN
XGN
Q4 25
$17.8M
$17.4M
Q3 25
$20.0M
$18.1M
Q2 25
$18.7M
$21.0M
Q1 25
$19.0M
$6.4M
Q4 24
$19.6M
$9.5M
Q3 24
$18.2M
$12.9M
Q2 24
$19.0M
$17.6M
Q1 24
$20.8M
$20.0M
Total Assets
SYPR
SYPR
XGN
XGN
Q4 25
$107.8M
$58.0M
Q3 25
$112.5M
$62.8M
Q2 25
$105.8M
$58.8M
Q1 25
$110.2M
$40.3M
Q4 24
$119.4M
$44.7M
Q3 24
$121.6M
$43.6M
Q2 24
$124.2M
$49.3M
Q1 24
$129.0M
$50.8M
Debt / Equity
SYPR
SYPR
XGN
XGN
Q4 25
1.31×
Q3 25
1.26×
Q2 25
1.09×
Q1 25
3.27×
Q4 24
2.12×
Q3 24
1.57×
Q2 24
1.15×
Q1 24
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SYPR
SYPR
XGN
XGN
Operating Cash FlowLast quarter
$-1.1M
$-3.0M
Free Cash FlowOCF − Capex
$-1.5M
$-3.1M
FCF MarginFCF / Revenue
-5.0%
-18.4%
Capex IntensityCapex / Revenue
1.3%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.5M
$-14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SYPR
SYPR
XGN
XGN
Q4 25
$-1.1M
$-3.0M
Q3 25
$-178.0K
$2.9M
Q2 25
$1.1M
$-2.9M
Q1 25
$-5.5M
$-10.7M
Q4 24
$2.3M
$363.0K
Q3 24
$-4.8M
$-2.2M
Q2 24
$6.2M
$-2.4M
Q1 24
$-1.7M
$-9.0M
Free Cash Flow
SYPR
SYPR
XGN
XGN
Q4 25
$-1.5M
$-3.1M
Q3 25
$-390.0K
$2.7M
Q2 25
$941.0K
$-3.1M
Q1 25
$-5.5M
$-10.8M
Q4 24
$1.9M
$217.0K
Q3 24
$-4.9M
$-2.3M
Q2 24
$6.0M
$-2.6M
Q1 24
$-2.0M
$-9.1M
FCF Margin
SYPR
SYPR
XGN
XGN
Q4 25
-5.0%
-18.4%
Q3 25
-1.4%
15.5%
Q2 25
3.0%
-18.0%
Q1 25
-18.8%
-69.6%
Q4 24
5.7%
1.6%
Q3 24
-13.8%
-18.6%
Q2 24
16.8%
-17.0%
Q1 24
-5.7%
-63.3%
Capex Intensity
SYPR
SYPR
XGN
XGN
Q4 25
1.3%
0.3%
Q3 25
0.7%
1.6%
Q2 25
0.5%
1.2%
Q1 25
0.0%
0.7%
Q4 24
1.2%
1.1%
Q3 24
0.4%
1.2%
Q2 24
0.5%
0.9%
Q1 24
0.9%
0.6%
Cash Conversion
SYPR
SYPR
XGN
XGN
Q4 25
Q3 25
-0.34×
Q2 25
Q1 25
Q4 24
17.13×
Q3 24
-12.21×
Q2 24
385.25×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SYPR
SYPR

Sypris Electronics$17.7M59%
Transferred At Point In Time$12.5M41%

XGN
XGN

Commercial$9.3M56%
Government1$4.3M26%
Client Direct Bill$2.9M18%

Related Comparisons